Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler® and Diskus® powder devices in patients with mild-to-moderate asthma

Clinical Pharmacokinetics

Volumn 39, Issue SUPPL. 1, 2000, Pages 31-37

  Falcoz, Christine ^a,d   Horton, John ^a   Mackie, Alison E ^b   Harding, Stuart M ^c   Daley Yates, Peter T ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRY POWDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033673466     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200039001-00005     Document Type: Article

References (4)

1. Mackie AE, McDowall JE, Falcoz C, et al. Pharmacokinetics of flulicasone propionate inhaled via the Diskhaler® and Diskus® powder devices in healthy volunteers. Clin Pharmacokinet 2000; 39 Suppl. 1: 23-30
2. Rowland M, Tozer TN, editors. Clinical pharmacokinetics: concepts and applications. 3rd ed. Philadelphia: Williams & Wilkins, 1995
3. Mackie AE, Bye A. The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers. Clin Pharmacokinet 2000; 39 Suppl. 1: 47-54
4. Daley-Yates ET, Tournant J, Kunka RL. Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma. Clin Pharmacokinet 2000; 39 Suppl. 1: 39-45